BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- The Cleveland Clinic
- Study ID
- NCT07138560
- Phase
- PHASE4
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- CREXONT ER — DRUGexploring shorter dose intervals of Crexont (IPX203) and allowing for higher dosing frequency, as practiced in real-world settings, combined with objective monitoring of on-time periods
Study Details
The purpose of this study is to evaluate the effect of IPX203 (Crexont®) - the newest extended-release levodopa formulation - on the duration and quality of good on time, using a wearable device to monitor symptoms. 'Good on time' refers to a period (minutes to hours) when a patient experiences optimal symptom control due to effective medication and has better overall functioning without troublesome dyskinesias. The change in the duration and quality of on-time will be measured by a wearable device placed on your wrist called KinesiaU.
Key Dates
- Start date
- Jul 24, 2025
- Status verified
- Aug 2025
- Primary completion
- May 15, 2026
- Completion
- May 15, 2027
Study Design
- Enrollment
- 22 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: Intervention ArmThe intervention arm will be patients converting to shorter dose intervals of Crexont (IPX203) and allowing for higher dosing frequency, as practiced in real-world settings, combined with objective monitoring of on-time periods and other parameters using the KinesiaU device, could reveal additional benefits of Crexont (IPX203) treatment.
Primary Outcome Measure
Primary Endpoint [ Time Frame: 8 weeks ]
Central Contacts
- Saar Anis, MD216 678-8896
- Mary Carmell Beukemann216-372-2867
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 | - |
Find similar trials in Cleveland, OH
By condition
By specialty
By research site
Related Studies
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- Study in Parkinson Disease of ExerciseRecruiting · Northwestern University · Birmingham, Alabama
- PPMI Clinical - Establishing a Deeply Phenotyped PD CohortRecruiting · Michael J. Fox Foundation for Parkinson's Research · Birmingham, Alabama
- Personalized Real-Time DBS and PD MechanismsPHASE4 · Recruiting · David Escobar · Cleveland, Ohio